Medtronic touts 3-year data for Evolut TAVR
Medtronic (NYSE:MDT) announced three-year data supporting its Evolut transcatheter aortic valve replacement (TAVR) system.
Source: massdevice.com
Page 26 - Structural Heart News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Structural Heart. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Structural Heart Today - Breaking & Trending Today
Transcatheter Tricuspid Valve Repair Effective, Safe for Regurgitation: TRILUMINATE
TRILUMINATE, the first pivotal trial of a device for repair of severe tricuspid regurgitation, showed a large reduction in valve dysfunction associated with substantial improvement in quality of life.
Source: medscape.com
Aidoc Introduces Cardiovascular Solutions to Connect the Dots in Patient Care Through the Power of Enterprise-Wide AI
/PRNewswire/ -- Aidoc, the leading provider of healthcare AI solutions, today launched its premier, first-of-its-kind cardiovascular AI solutions package...
Source: prnewswire.com
Medtronic: Healthcare Inequity: Heart Disease in Women
NORTHAMPTON, MA / ACCESSWIRE / March 2, 2023 / Medtronic:When it comes to detecting and treating heart disease, the healthcare system often tilts in favor of men."Heart disease is regularly undetected
Source: finanznachrichten.de
Why Abbott Laboratories Stock Bumped Higher Today
The company's specialized heart care products appear to prove their value in clinical testing.
Source: fool.com